Skip to content

Drug interactions

Hydrochlorothiazide-losartan + Lorlatinib

Severity: Minor

Hydrochlorothiazide-losartan and Lorlatinib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lorlatinib induces CYP3A4 and may lower losartan exposure. Because losartan is also metabolized by CYP2C9, the effect on antihypertensive response is probably small.

What this interaction means in plain words

Hydrochlorothiazide-losartan and Lorlatinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Hydrochlorothiazide-losartan belongs to Cardiovascular; Lorlatinib belongs to Oncology.

Evidence level: Low

Why it happens

Lorlatinib induction of CYP3A4 may increase losartan metabolism.

What to do

No routine dose change is needed. Monitor blood pressure during lorlatinib therapy and adjust antihypertensive dosing if control declines.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Hydrochlorothiazide-losartan and Lorlatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Hydrochlorothiazide-losartan with Lorlatinib?

MediHelp rates the interaction as minor. Hydrochlorothiazide-losartan and Lorlatinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Lorlatinib induces CYP3A4 and may lower losartan exposure. Because losartan is also metabolized by CYP2C9, the effect on antihypertensive response is probably small.

How serious is the interaction between Hydrochlorothiazide-losartan and Lorlatinib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine dose change is needed. Monitor blood pressure during lorlatinib therapy and adjust antihypertensive dosing if control declines.

What other medicines interact with Hydrochlorothiazide-losartan?

MediHelp also lists interactions of Hydrochlorothiazide-losartan with, for example, Aliskiren, Dofetilide, Sparsentan. The full list is on the Hydrochlorothiazide-losartan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in